DK0535150T3 - Humant makrofag-inflammatorisk protein-2-beta - Google Patents

Humant makrofag-inflammatorisk protein-2-beta

Info

Publication number
DK0535150T3
DK0535150T3 DK91913167.2T DK91913167T DK0535150T3 DK 0535150 T3 DK0535150 T3 DK 0535150T3 DK 91913167 T DK91913167 T DK 91913167T DK 0535150 T3 DK0535150 T3 DK 0535150T3
Authority
DK
Denmark
Prior art keywords
beta
mip
macrophage inflammatory
human
inflammatory protein
Prior art date
Application number
DK91913167.2T
Other languages
Danish (da)
English (en)
Inventor
Patricia Tekamp-Olson
Carol Ann Gallegos
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Application granted granted Critical
Publication of DK0535150T3 publication Critical patent/DK0535150T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK91913167.2T 1990-06-22 1991-06-24 Humant makrofag-inflammatorisk protein-2-beta DK0535150T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54189890A 1990-06-22 1990-06-22
US71519591A 1991-06-19 1991-06-19

Publications (1)

Publication Number Publication Date
DK0535150T3 true DK0535150T3 (da) 1995-05-15

Family

ID=27066836

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91913167.2T DK0535150T3 (da) 1990-06-22 1991-06-24 Humant makrofag-inflammatorisk protein-2-beta

Country Status (11)

Country Link
EP (1) EP0535150B1 (es)
JP (1) JPH06501244A (es)
AT (1) ATE118018T1 (es)
CA (1) CA2086088A1 (es)
DE (1) DE69107209T2 (es)
DK (1) DK0535150T3 (es)
ES (1) ES2069303T3 (es)
GR (1) GR3015284T3 (es)
IE (1) IE66227B1 (es)
PT (1) PT98073B (es)
WO (1) WO1992000326A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145676A (en) * 1981-09-08 1992-09-08 The Rockefeller University Method and agents for promoting wound healing
CA2092924A1 (en) * 1990-09-28 1992-03-29 John Stephen Haskill Gro genes, proteins, and uses thereof
US6811773B1 (en) 1993-12-22 2004-11-02 Human Genome Sciences, Inc. Human monocyte colony inhibitory factor (M-CIF) polypeptides
US6001606A (en) * 1994-03-08 1999-12-14 Human Genome Sciences, Inc. Polynucleotides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) and polypeptides encoded thereby
US6451562B1 (en) 1993-12-22 2002-09-17 Human Genome Sciences, Inc. Polypeptides encoding myeloid progenitor inhibitory factor-1 (MPIF-1) polynucleotides
US5504003A (en) * 1994-03-08 1996-04-02 Human Genome Sciences, Inc. Macrophage inflammatory protein-3 and -4
US6488925B2 (en) 1993-12-22 2002-12-03 Human Genome Sciences, Inc. Macrophage inflammatory protein-4 (MIP-4) polypeptides
US6495129B1 (en) 1994-03-08 2002-12-17 Human Genome Sciences, Inc. Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3)
AU1020997A (en) * 1995-11-21 1997-06-11 Smithkline Beecham Corporation Method of treating sepsis
US5981231A (en) 1996-06-17 1999-11-09 Human Genome Sciences, Inc. Polynucleotides encoding chemokine β-15
GB0024283D0 (en) * 2000-10-04 2000-11-15 Inpharmatica Ltd Novel proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68928124T2 (de) * 1988-09-02 1997-10-16 Chiron Corp., Emeryville, Calif. Makrophagenabgeleiteter entzündungsmediator(mip-2)

Also Published As

Publication number Publication date
EP0535150B1 (en) 1995-02-01
GR3015284T3 (en) 1995-06-30
IE912193A1 (en) 1992-01-01
PT98073B (pt) 1998-11-30
DE69107209T2 (de) 1995-05-24
IE66227B1 (en) 1995-12-13
EP0535150A1 (en) 1993-04-07
WO1992000326A1 (en) 1992-01-09
ATE118018T1 (de) 1995-02-15
PT98073A (pt) 1992-03-31
CA2086088A1 (en) 1991-12-23
ES2069303T3 (es) 1995-05-01
JPH06501244A (ja) 1994-02-10
DE69107209D1 (de) 1995-03-16

Similar Documents

Publication Publication Date Title
Otey et al. Identification and quantification of actin isoforms in vertebrate cells and tissues
ES2047334T3 (es) Metodo de analisis optico.
BR9809443A (pt) Polipeptìdeo compreendendo uma porção antigênica de um antìgeno de m. tuberculosis, molécula de dna, vetor recombinante de expressão, célula hospedeira, processo para detecção de infecção de m. tuberculosis em uma amostra biológica, kit de diganóstico, anticorpo monoclonal, anticorpo policlonal, e, proteìna de fusão.
CA2131826A1 (en) MN Gene and Protein
BR9712298A (pt) Polipeptìdeo, molécula de dna, vetor de expressão recombinante, célula hospedeira, processo para detectar infecção por m. tuberculosis em uma amostra biológica, kit diagnóstico, anticorpos monoclonal, e, policlonal, e, proteìna de fusão
NL300120I1 (nl) Voor Factor VIIIC coderende DNA-sequenties en verwante DNA-constructen.
DK0535150T3 (da) Humant makrofag-inflammatorisk protein-2-beta
FI913637A0 (fi) Foer epitelceller specifik dna kodande vaextfaktor.
DK0914344T3 (da) Assay og reagenser til kvantificering af hBNP
SE9500023L (sv) Sätt att detektera cancer
NO172394C (no) Antigent, syntetisk polypeptid, anvendelse derav til in vitro diagnose, vannopploeselig eller vanndisperbar antigen polymer, reseptormolekyl og diagnostisk proevesystem for bestemmelse av tilstedevaerelse av hbxag i en kroppsvaeske
DE3853718D1 (de) Menschliche gamma, delta-t-zellen-antigen-rezeptor-polypeptide und nukleinsäuren.
AU3618095A (en) Alk-7 (activin like kinase), a serine threonine kinase receptor
DE69018968D1 (de) BLUTGERINNUNGSFAKTOR BETA XIIa MONOKLONALE ANTIKÖRPER UND IMMUNANALYSE.
ATE230418T1 (de) Monoklonaler antikörper gegen das humane mx- protein mxa
SE8900899D0 (sv) Peptides for diagnostic use
DE69121861D1 (de) Peptide von sm-d-antigen, deren benützung zum nachweis von disseminierten lupus-erythemateux
DK414386A (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
Stott Protein blotting: Baldo, BA and Tovey, ER (Eds.) viii+ 168 pp. Karger, Basel, 1989. GBP 50.90 ISBN 3-8055-4881-8
Sakai et al. A study on temperature dependence of flexural strength distribution for alumina ceramics